PTC Therapeutics PTCT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from PTC Therapeutics’s reported figures.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's enterprise value?
- PTC Therapeutics (PTCT) reported enterprise value of $5.2B in Q1 2026.
- How has PTC Therapeutics's enterprise value changed year-over-year?
- PTC Therapeutics's enterprise value increased by 77.3% year-over-year, from $2.93B to $5.2B.
- What is the long-term trend for PTC Therapeutics's enterprise value?
- Over 5 years (2020 to 2025), PTC Therapeutics's enterprise value has grown at a 4.0% compound annual growth rate (CAGR), from $4.53B to $5.51B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.